2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow MM-141: new trials by email Literature Review of MM-141 trials Research Report on MM-141
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib MM-151, MM-121, MM-141 - Colorectal Cancer, Non-small Cell Lung Cancer | Phase 1 | Terminated | Merrimack Pharmaceuticals | 5 | 2015-08-01 | 2017-09-05 |
| A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer MM-141, Placebo, Gemcitabine - Pancreatic Cancer | Phase 2 | Completed | Merrimack Pharmaceuticals | 88 | 2015-05-01 | 2018-09-18 |
| A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors MM-141 - Hepatocellular Carcinoma | Phase 1 | Completed | Merrimack Pharmaceuticals | 42 | 2012-11-01 | 2016-08-04 |
Neoplasms (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Fibromatosis, Gingival, 2 (1) · Insulin-Like Growth Factor I, Resistance To (1) · Pancreatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
United States (3) · Canada (1) · France (1) · Germany (1) · Poland (1) · Spain (1) · United Kingdom (1)